MENU
APRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aprea Therapeutics (APRE) Ownership - Who owns Aprea Therapeutics?
Profile
Industry
N/A
Address
3805 Old Easton Road
Phone
+1 617 463-9385
Employees
7
Web
https://www.aprea.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.15M
P/E Ratio
N/A
Total Cash
26.25M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.93
Dividend Yield
N/A
Total Cash/Share
4.83
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
APRE
Capitalization
18.2M
P/E Ratio
N/A
Risk (Beta)
1.93
Dividend Yield
N/A
Total Cash
26.2M
Total Cash/Share
4.83
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
21.9M
P/B Ratio
0.76
Cash Flow
N/A
Earnings
-2.8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5.44K
Current Ratio
7.28
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-14.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-51.30
Shares Held By Institutions
9.3M
Shares Outstanding - Current
5.44M
Total Liabilities
4.95M
Total Volume MTD
N/A
Value
1
Gain YTD
-28.936
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3805 Old Easton Road
Phone
+1 617 463-9385
Employees
7
Web
https://www.aprea.com